MBSD | SCHR | MBSD / SCHR | |
Gain YTD | 2.427 | 3.412 | 71% |
Net Assets | 83.6M | 10.7B | 1% |
Total Expense Ratio | 0.20 | 0.03 | 667% |
Turnover | 31.00 | 38.00 | 82% |
Yield | 3.98 | 3.78 | 105% |
Fund Existence | 11 years | 15 years | - |
MBSD | SCHR | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago49% | 2 days ago47% |
Momentum ODDS (%) | 2 days ago36% | 2 days ago42% |
MACD ODDS (%) | 2 days ago42% | 2 days ago45% |
TrendWeek ODDS (%) | 2 days ago43% | 2 days ago44% |
TrendMonth ODDS (%) | 2 days ago46% | 2 days ago48% |
Advances ODDS (%) | 8 days ago47% | 8 days ago42% |
Declines ODDS (%) | 4 days ago42% | 4 days ago42% |
BollingerBands ODDS (%) | N/A | 2 days ago39% |
Aroon ODDS (%) | N/A | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPXU | 19.24 | 0.28 | +1.48% |
ProShares UltraPro Short S&P500 | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
EMHC | 24.11 | -0.04 | -0.17% |
SPDR® Bloomberg EM USD Bd ETF | |||
UITB | 46.56 | -0.08 | -0.18% |
VictoryShares Core Intermediate Bond ETF | |||
LEAD | 70.18 | -0.47 | -0.67% |
Siren DIVCON Leaders Dividend ETF |